Chief Executive Officer
Wed, Jan 15, 2020
Jan 15
exercised or converted securities in APLS
30,638 shares @ $0.00
Decreased holdings by -16.70%
Option Exercise
Sale tied to a same-time option exercise
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology